We attributed this to the fact that clopidogrel administration did not commence until 24 h post-stroke, meaning microglia had sufficient time to migrate toward and phagocytose dead or dying neurons within the peri-infarct region before clopidogrel reached therapeutic levels that blocked P2RY12-mediated functions. The gene discussed is P2RY12; the disease is stroke disorder.